Skip to main content
Fig. 1 | Cancer Communications

Fig. 1

From: Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases

Fig. 1

Lesions in case 1. Gd-EOB-DTPA-enhanced MR images showing, at baseline acquisition, hepatobiliary phase 4 millimetric lesions: a 10 mm hepatocellular carcinoma (HCC) nodule in segment II (a), a 14 mm HCC nodule in segment III (b), and a millimetric lesion at segments V and I. Gd-EOB-DTPA-enhanced MR follow-up after 89 months since starting systemic treatment with metronomic capecitabine shows a stable complete response, with the absence of both HCC nodules (c, d)

Back to article page